Special Podcast: CPhI Outlook Roundtable - Listen Now
In this special roundtable podcast exploring potential opportunities in a post-vaccinated world, we are joined by a panel of three world class experts – Bikash Chatterjee, CEO of Pharmatech Associates; Parrish Galliher, Managing Director, BioProcess Technology Group, a division of BDO USA and Valdas Jurkauskas, PhD, VP Technical Operations at Black Diamond Therapeutics.
The panel discusses insights into what new discoveries and technologies might offer the best potential, the approvals we might see in the next few years, and what might be the long-term positive COVID legacies – from speed of innovation and clinical trials, to proprietary information exchange and the global supply chain.
To download a copy of the CPhI Post Pandemic Legacy Trends Report, please click here
Related News
-
News Matica Bio and Sartorius form large-scale vector production research pact
Together the companies will attempt to overcome "black box" challenges to enable more robust and consistent results for clients -
News Avid Bioservices to plug capacity gap with new viral vector manufacturing facility
The biologics CDMO says it expects its new 53,000-sq.ft facility will be operational within 18 months -
News Merck KGaA doubles gene therapy capacity with opening of second Carlsbad CDMO facility
The new the 140,000-sq. ft facility will support commercialisation and industrialisation of viral vectors -
News Aceto boosts biomanufacturing footprint with acquisition of Ireland-based A&C Bio Buffer
The transaction expands the CDMO's GMP biopharmaceutical and vaccine manufacturing capabilities -
News Boehringer opens doors to new Austrian biopharma production site
The LSCC provides an additional 30% in mammalian large-scale capacity for the company's own pipeline and for third parties -
News Forge Biologics to provide CDMO support for Solid Biosciences' preclinical gene therapy
By providing AAV process development, scale up and cGMP manufacturing services, Forge hopes to bolster Solid's gene therapy pipeline -
News Thermo Fisher takes on operational responsibility for new Swiss biologics manufacturing site
The 1.5 million-sq. ft Switzerland-based facility is part of the company's strategic partnership with CSL Limited -
News Advanced Computing in Pharma: 3 reasons why quantum computing could disrupt R&D
Quantum computing technology uses quantum systems called “qubits”. They work with non-binary values, unlike classical computing which uses only bits with values of 0 or 1, and can overlap each other and act as a group. The result is a ...
Position your company at the heart of the global Pharma industry with a CPhI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPhI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance